Document Detail


Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age </=27 weeks).
MedLine Citation:
PMID:  17359406     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Spontaneous breathing supported by nasal continuous positive airway pressure (nCPAP) is thought to have some advantages compared with mechanical ventilation in extremely premature infants. In addition, early or prophylactic surfactant administration has been shown to be superior to delayed use. A strategy to combine these two principles was tested in our neonatal intensive care unit (NICU). The aim of this feasibility study was to describe the procedure and compare short-term results with a historical control. METHODS: The study took place in a level III NICU. In the observational period all extremely premature infants with clinical signs of moderate to severe respiratory distress syndrome despite nCPAP received 100 mg.kg(-1) of a natural surfactant preparation via an intratracheal catheter during spontaneous breathing. In the historical control period those infants were intubated and ventilated to receive surfactant. RESULTS: Twenty-nine of 42 infants fulfilled the criteria and were treated with the new approach. In five cases ventilation with manual bag was necessary after administration of surfactant but all infants could be retransferred to nCPAP within a few minutes. Ten infants were intubated later during the first 3 days. Mortality was 7% in the group of infants treated in this way and 12% in all infants treated during the observational period. Mortality was 35% in the historical control period. Morbidity was within ranges reported by other authors. CONCLUSIONS: Surfactant administration during nCPAP is feasible. First results indicate that early complications are rare. This warrants a prospective randomized trial.
Authors:
Angela Kribs; Frank Pillekamp; Christoph Hünseler; Anne Vierzig; Bernhard Roth
Related Documents :
20500436 - Viral bronchiolitis for the clinician.
16106356 - Leukotriene synthesis during respiratory syncytial virus bronchiolitis: influence of ag...
22585916 - Structure-function relationships of human milk oligosaccharides.
23436176 - Cystatin c adaptation in the first month of life.
9071366 - Psychobiology of early social attachment in rhesus monkeys. clinical implications.
17697076 - Outcomes of preterm children according to type of delivery onset: a nationwide populati...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Paediatric anaesthesia     Volume:  17     ISSN:  1155-5645     ISO Abbreviation:  Paediatr Anaesth     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-03-15     Completed Date:  2007-06-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9206575     Medline TA:  Paediatr Anaesth     Country:  France    
Other Details:
Languages:  eng     Pagination:  364-9     Citation Subset:  IM    
Affiliation:
Department of Neonatology, Children's Hospital, University of Cologne, Cologne, Germany. angela.kribs@uk-koeln.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Products / adverse effects,  therapeutic use*
Cohort Studies
Continuous Positive Airway Pressure / methods*
Feasibility Studies
Female
Gestational Age
Humans
Infant, Extremely Low Birth Weight
Infant, Newborn
Infant, Premature
Infant, Very Low Birth Weight
Male
Pulmonary Surfactants / adverse effects,  therapeutic use*
Respiratory Distress Syndrome, Newborn / therapy*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Biological Products; 0/Pulmonary Surfactants; 108778-82-1/beractant

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Procedural sedation for insertion of central venous catheters in children: comparison of midazolam/f...
Next Document:  A combination of total intravenous anesthesia and thoracic epidural for thymectomy in juvenile myast...